MX2017006227A - Sistema de administración de óxido nítrico y métodos de uso. - Google Patents

Sistema de administración de óxido nítrico y métodos de uso.

Info

Publication number
MX2017006227A
MX2017006227A MX2017006227A MX2017006227A MX2017006227A MX 2017006227 A MX2017006227 A MX 2017006227A MX 2017006227 A MX2017006227 A MX 2017006227A MX 2017006227 A MX2017006227 A MX 2017006227A MX 2017006227 A MX2017006227 A MX 2017006227A
Authority
MX
Mexico
Prior art keywords
methods
delivery system
nitric oxide
subject
gno
Prior art date
Application number
MX2017006227A
Other languages
English (en)
Inventor
Jensen Jeffrey
Packert Gerhild
C Miller Christopher
Packert Daniel
Original Assignee
Hansen Pharmaceutical Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hansen Pharmaceutical Llc filed Critical Hansen Pharmaceutical Llc
Publication of MX2017006227A publication Critical patent/MX2017006227A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M13/00—Insufflators for therapeutic or disinfectant purposes, i.e. devices for blowing a gas, powder or vapour into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M35/00—Devices for applying media, e.g. remedies, on the human body
    • A61M35/30—Gas therapy for therapeutic treatment of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/02—Gases
    • A61M2202/0266—Nitrogen (N)
    • A61M2202/0275—Nitric oxide [NO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/20—Pathogenic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/20—Pathogenic agents
    • A61M2202/203—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/20—Pathogenic agents
    • A61M2202/206—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/33—Controlling, regulating or measuring
    • A61M2205/3327—Measuring

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Modalidades de la presente descripción proporcionan sistemas y dispositivos para administrar Óxido Nítrico gaseoso (gNO) bajo parámetros terapéuticos para reducir infección en un sujeto. Ciertas modalidades incluyen dispositivos y sistemas para administrar gNO presurizado para reducir carga bacteriana biológica y promover curación en las heridas de sujetos que tienen condiciones de enfermedad, que incluyen, pero no se limitan a, infecciones de la piel y tejidos blandos (SSTI) y osteomielitis. En algunas modalidades, la presente descripción proporciona dispositivos portátiles de curación de heridas para administrar Gno presurizado al sitio de una herida para tratar diferentes condiciones de enfermedad en un sujeto.
MX2017006227A 2014-11-13 2015-11-12 Sistema de administración de óxido nítrico y métodos de uso. MX2017006227A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462079461P 2014-11-13 2014-11-13
PCT/US2015/060461 WO2016077635A1 (en) 2014-11-13 2015-11-12 Nitric oxide delivery system and methods of use

Publications (1)

Publication Number Publication Date
MX2017006227A true MX2017006227A (es) 2018-02-09

Family

ID=54704119

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017006227A MX2017006227A (es) 2014-11-13 2015-11-12 Sistema de administración de óxido nítrico y métodos de uso.

Country Status (6)

Country Link
US (1) US10391266B2 (es)
EP (1) EP3218042A1 (es)
AU (1) AU2015346202A1 (es)
CA (1) CA2967802A1 (es)
MX (1) MX2017006227A (es)
WO (1) WO2016077635A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11524127B2 (en) * 2019-11-25 2022-12-13 Beyond Air, Inc. System and method for delivery of gas to a tissue
JP2023524152A (ja) * 2020-05-04 2023-06-08 フィッシャー アンド ペイケル ヘルスケア リミテッド 創縁拡散器
USD1011523S1 (en) 2021-09-27 2024-01-16 Fisher & Paykel Healthcare Limited Surgical gas diffuser

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2254645A1 (en) 1998-11-23 2000-05-23 Pulmonox Medical Corporation Method and apparatus for treatment of respiratory infections by nitric oxide inhalation
US6432077B1 (en) 2000-12-26 2002-08-13 Sensormedics Corporation Device and method for treatment of surface infections with nitric oxide
US7122018B2 (en) * 2000-12-26 2006-10-17 Sensormedics Corporation Device and method for treatment of wounds with nitric oxide
US20020155164A1 (en) * 2001-04-18 2002-10-24 Curtis Figley System and method for the prevention of infections in human patients using nitric oxide
DE10335732A1 (de) * 2003-08-05 2005-02-24 Daimlerchrysler Ag Verfahren zum Ändern des Beschleunigungsmodus eines Kraftfahrzeugs
EP1755715A4 (en) 2004-05-11 2010-03-24 Sensormedics Corp INTERMITTENT DETERMINATION OF GASEOUS NITRIC OXIDE
US20060191535A1 (en) * 2005-02-25 2006-08-31 The Nemours Foundation Treatment of decompression sickness with inhaled nitric oxide gas
US20080193566A1 (en) * 2007-02-09 2008-08-14 Miller Christopher C Use of high dose concentrations of gaseous nitric oxide
US20090216204A1 (en) * 2008-02-27 2009-08-27 Sai Bhavaraju Auto-replenishing, wound-dressing apparatus and method
WO2010014818A1 (en) 2008-07-30 2010-02-04 Nitric Biotherapeutics, Inc. Methods of treating an infection with nitric oxide
JP5736383B2 (ja) * 2009-10-23 2015-06-17 アミール ベルソン， 可搬性局所的酸素療法システム
EP2552508A2 (en) * 2010-03-31 2013-02-06 Koninklijke Philips Electronics N.V. Wound care system
US9364388B2 (en) * 2012-09-27 2016-06-14 Barry university Methods of treatment with nitric oxide at pressures greater than one atmosphere
US20160137968A1 (en) 2014-11-13 2016-05-19 Barry university Tissue culture testing systems and methods of use

Also Published As

Publication number Publication date
WO2016077635A1 (en) 2016-05-19
US10391266B2 (en) 2019-08-27
EP3218042A1 (en) 2017-09-20
US20160136364A1 (en) 2016-05-19
CA2967802A1 (en) 2016-05-19
AU2015346202A1 (en) 2017-06-08

Similar Documents

Publication Publication Date Title
MX2021004546A (es) Composiciones de suministro de farmaco implantables y metodos de uso de las mismas.
MX2015012322A (es) Uso de levocetirizina y montelukast en el tratamiento de trastornos autoinmunes.
MX2012014521A (es) Uso de levocetirizina y montelukast en el tratamiento de influenza, resfriado comun e inflamacion.
MX2016010532A (es) Sistemas y metodos para cicatrizacion de tejido.
MX2016005532A (es) Metodos para usar oxido nitrico en un estado de plasma para tratar condiciones medicas y enfermedades.
WO2014153473A3 (en) Methods and apparatus for reducing the risk of surgical site infections
MX2017017138A (es) Conjugados homogeneos especificos de sitio con inhibidores de ksp.
MX2015012315A (es) Uso de levocetirizina y montelukast en el tratamiento de lesion traumatica.
WO2014164285A3 (en) Use of levocetirizine and montelukast in the treatment of vasculitis
MX2015011775A (es) Uso de levocetirizina y montelukast en el tratamiento de anafilaxis.
SA519400913B1 (ar) تركيبة موضعية لتعزيز إلتئام الجروح
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
PH12017500392A1 (en) Medical treatments based on anamorelin
MX2017006227A (es) Sistema de administración de óxido nítrico y métodos de uso.
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
MX2018005876A (es) Regimen de dosificacion de plasminogeno para la cicatrizacion de heridas.
BR112015028334A2 (pt) agente e método para o tratamento de herpes
MX2020004518A (es) Suministro asistido de manera magnética al interior y a través de la piel.
Girard Evidence appraisal of Harman S, Zemek R, Duncan MJ, Ying Y, Petrcich W. Efficacy of pain control with topical lidocaine-epinephrine-tetracaine during laceration repair with tissue adhesive in children: a randomized controlled trial. CMAJ. 2013; 185 (13): E629-E634
UA120024U (uk) Спосіб консервативного лікування гнійних ран у хворих з флегмонами підщелепної ділянки
MD757Y (en) Method for treating burns of I...IIIB degree
AR106220A1 (es) Conjugados homogéneos específicos de sitio con inhibidores de ksp
ITSI20120004U1 (it) Cerotto sterile monouso per accelerare la guarigione di ferite e piaghe usando l'ossigenoterapia in uso locale su ogni parte del corpo.
GB201501717D0 (en) Galactose polymer gel dressing for wound healing and as a means of passive or active transdermal delivery of remedial agents
UA64165U (ru) Способ лечения пациентов с травмами мягких тканей конечностей